Maintenance treatment with bevacizumab prolongs survival in an in vivo ovarian cancer model.
Mabuchi S, Terai Y, Morishige K, Tanabe-Kimura A, Sasaki H, Kanemura M, Tsunetoh S, Tanaka Y, Sakata M, Burger RA, Kimura T, Ohmichi M.
Mabuchi S, et al.
Clin Cancer Res. 2008 Dec 1;14(23):7781-9. doi: 10.1158/1078-0432.CCR-08-0243.
Clin Cancer Res. 2008.
PMID: 19047105